Intravenous iron for treatment of Anemia in the 3 perisurgical phases: A review and analysis of the current literature

Anesthesia and Analgesia

Volumn 126, Issue 4, 2018, Pages 1268-1282

  Peters, Frank ^a   Ellermann, Ines ^a   Steinbicker, Andrea U ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON; ANTIANEMIC AGENT; BIOLOGICAL MARKER; IRON DERIVATIVE;

ANEMIA; ERYTHROCYTE CONCENTRATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON THERAPY; LENGTH OF STAY; META ANALYSIS; OBSERVATIONAL STUDY; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETICULOCYTE COUNT; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; BLOOD; BLOOD TRANSFUSION; DRUG ADMINISTRATION; HOSPITAL PATIENT; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PROCEDURES; RISK FACTOR; TIME FACTOR;

ADMINISTRATION, INTRAVENOUS; ANEMIA; BIOMARKERS; BLOOD TRANSFUSION; DRUG ADMINISTRATION SCHEDULE; HEMATINICS; HEMOGLOBINS; HOSPITALIZATION; HUMANS; INPATIENTS; IRON COMPOUNDS; PERIOPERATIVE CARE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85051378869     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000002591     Document Type: Review

References (35)

1. Steinbicker AU, Muckenthaler MU. Out of balance-systemic iron homeostasis in iron-related disorders. Nutrients. 2013;5:3034-3061.
2. Papanikolaou G, Pantopoulos K. Systemic iron homeostasis and erythropoiesis. IUBMB Life. 2017;69:399-413.
3. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142:24-38.
4. Napolitano LM. Anemia and red blood cell transfusion: advances in critical care. Crit Care Clin. 2017;33:345-364.
5. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014;311:1317-1326.
6. Cappellini MD, Comin-Colet J, de Francisco A, et al; IRON CORE Group. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92:1068-1078.
7. Auerbach M, Adamson J, Bircher A, et al. On the safety of intravenous iron, evidence trumps conjecture. Haematologica. 2015;100:e214-e215.
8. Shander A, Goodnough LT, Javidroozi M, et al. Iron deficiency anemia-bridging the knowledge and practice gap. Transfus Med Rev. 2014;28:156-166.
9. Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017;72:233-247.
10. Atkins D, Best D, Briss PA, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
11. Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305-310.
12. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Auerbach M. Perioperative anemia management in colorectal cancer patients: a pragmatic approach. World J Gastroenterol. 2014;20:1972-1985.
13. Society for the Advancement of Blood Management (SABM. org). Available at: http://iron.sabm.org/overview/docs/iron_table.pdf. Accessed June 15, 2017.
14. Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol. 2004;15(SUPPL. 2):S93-S98.
15. Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus. 2014;12:296-300.
16. Kopanidis P, Hardidge A, McNicol L, Tay S, McCall P, Weinberg L. Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty. J Orthop Surg Res. 2016;11:28.
17. Lasocki S, Krauspe R, von Heymann C., Mezzacasa A, Chainey S, Spahn DR. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. Eur J Anaesthesiol. 2015;32:160-167.
18. Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929-937.
19. Rohling RG, Zimmermann AP, Breymann C. Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin. J Hematother Stem Cell Res. 2000;9:497-500.
20. Bernabeu-Wittel M, Romero M, Ollero-Baturone M, et al; PAHFRAC-01 Investigators. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion. 2016;56:2199-2211.
21. Calleja JL, Delgado S, del Val A, et al; Colon Cancer Study Group. Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. Int J Colorectal Dis. 2016;31:543-551.
22. Rineau E, Chaudet A, Chassier C., Bizot P, Lasocki S. Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study. Transfusion. 2016;56:673-681.
23. Laso-Morales M, Jerico C., Gomez-Ramirez S, et al. Preoperative management of colorectal cancer-induced iron deficiency anemia in clinical practice: data from a large observational cohort. Transfusion. 2017 August 21 [Epub ahead of print].
24. Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang. 2015;109:257-266.
25. Serrano-Trenas JA, Ugalde PF, Cabello LM, Chofles LC, Lázaro PS, Benítez PC. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion. 2011;51:97-104.
26. Muñoz M, Breymann C., García-Erce JA, Gómez-Ramírez S, Comin J, Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang. 2008;94:172-183.
27. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth. 2006;53:11-19.
28. Koch CG, Li L, Sun Z, et al. Magnitude of anemia at discharge increases 30-day hospital readmissions. J Patient Saf. 2014 [Epub ahead of print].
29. Litton E, Baker S, Erber WN, et al; IRONMAN Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness. Intensive Care Med. 2016;42:1715-1722.
30. Madi-Jebara SN, Sleilaty GS, Achouh PE, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18:59-63.
31. Bisbe Vives E, Moltó L. [Therapeutic approach to postoperative anemia]. Rev Esp Anestesiol Reanim. 2015;62:41-44.
32. Kim YW, Bae JM, Park YK, et al; FAIRY Study Group. Effect of intravenous ferric carboxymaltose on hemoglobin response among patients with acute isovolemic anemia following gastrectomy: the FAIRY randomized clinical trial. JAMA. 2017;317:2097-2104.
33. Khalafallah AA, Yan C., Al-Badri R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematol. 2016;3:e415-e425.
34. Jeong O, Park YK. Effect of intravenous iron supplementation for acute postoperative anemia in patients undergoing gastrectomy for gastric carcinoma: a pilot study. Ann Surg Oncol. 2014;21:547-552.
35. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J. Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. Blood Transfus. 2014;12:40-49.